journals.lww.com/lt/abstract/...
#liversky
journals.lww.com/lt/abstract/...
#liversky
💫 LIVER-PAM trial
📌 open-label, single-center, RCT
📌 174 adult pts randomized to MAP 85-90 mmHg or 65-70 mmHg first 24 hrs
📌 primary outcome: AKI incidence within 7 days
🔑 Did not reduce AKI incidence
#liversky
pubmed.ncbi.nlm.nih.gov/40774358/
💫 LIVER-PAM trial
📌 open-label, single-center, RCT
📌 174 adult pts randomized to MAP 85-90 mmHg or 65-70 mmHg first 24 hrs
📌 primary outcome: AKI incidence within 7 days
🔑 Did not reduce AKI incidence
#liversky
pubmed.ncbi.nlm.nih.gov/40774358/
www.thelancet.com/journals/lan...
#LiverSky #MedSky
www.thelancet.com/journals/lan...
#LiverSky #MedSky
www.thelancet.com/journals/lan...
#LiverSky #MedSky
www.thelancet.com/journals/lan...
#LiverSky #MedSky
George Papatheodoridis presenting with risk stratification.
#EASLCongress @easlnews.bsky.social
George Papatheodoridis presenting with risk stratification.
#EASLCongress @easlnews.bsky.social
gut.bmj.com/content/earl...
@bmj.com #GISky #IBDSky
gut.bmj.com/content/earl...
@bmj.com #GISky #IBDSky
- practical guidance to improve care in the first 24 hours as well as implementation strategy - congrats Stuart McPherson for driving this! #livertwitter
fg.bmj.com/content/earl...
- practical guidance to improve care in the first 24 hours as well as implementation strategy - congrats Stuart McPherson for driving this! #livertwitter
fg.bmj.com/content/earl...
https://go.nature.com/3Yv2nig
https://go.nature.com/3Yv2nig
Score of ≥3 was 84% predictive of steroid failure
- CRP ≥100mg/L (1 point)
- albumin ≤25g/L (1 point)
- UCEIS ≥4 (1 point) or ≥7 (2 points)
Will these pts benefit from early 'salvage' therapy instead of waiting till Day 3?
#IBDSky #GISky
gut.bmj.com/content/72/3...
Score of ≥3 was 84% predictive of steroid failure
- CRP ≥100mg/L (1 point)
- albumin ≤25g/L (1 point)
- UCEIS ≥4 (1 point) or ≥7 (2 points)
Will these pts benefit from early 'salvage' therapy instead of waiting till Day 3?
#IBDSky #GISky
gut.bmj.com/content/72/3...
Reply below, DM or send email to hopquestions@gmail.com.
No question too big or small.
Reply below, DM or send email to hopquestions@gmail.com.
No question too big or small.
#MedSky #PedSky #GastroSky
#MedSky #PedSky #GastroSky
#liversky
📍don’t delay AC
📍can hold AC for EGD for 48 hours
📍AC does NOT increase risk of bleeding from varices while you wait for EGD
#liversky
📍don’t delay AC
📍can hold AC for EGD for 48 hours
📍AC does NOT increase risk of bleeding from varices while you wait for EGD
✅ Overall, safe for treatment of alcohol use disorder in this population
Black box warning for chronic liver disease was REMOVED in 2013: 🚫 evidence of harm
🔑 Alcohol causes harm to the liver, naltrexone does NOT
Slides: #ALD-ALLY Lamia Haque #liversky
* Median age at cirrhosis diagnosis up from 56y in 1998 to 66y in 2022
* Proportion with ALD cirrhosis down from 80% to 58%
* Prevalence of cirrhosis peaked in 2024
* Survival has improved
#Liversky
* Median age at cirrhosis diagnosis up from 56y in 1998 to 66y in 2022
* Proportion with ALD cirrhosis down from 80% to 58%
* Prevalence of cirrhosis peaked in 2024
* Survival has improved
#Liversky
EASL Clinical Practice Guidelines on TIPS
✅Addresses all aspects of #TIPS in patients with #cirrhosis
Full text here: bit.ly/4hZuMUK
#LiverSky
@easlnews.bsky.social
EASL Clinical Practice Guidelines on TIPS
✅Addresses all aspects of #TIPS in patients with #cirrhosis
Full text here: bit.ly/4hZuMUK
#LiverSky
@easlnews.bsky.social
UST group has 90% who are bio-experienced compared to VDZ and anti-TNF group (30+%), leading to:
1. High 'persistence' cos lack of options
2. 'Lower' efficacy of UST
#IBDSky #GISky
academic.oup.com/ecco-jcc/adv...
UST group has 90% who are bio-experienced compared to VDZ and anti-TNF group (30+%), leading to:
1. High 'persistence' cos lack of options
2. 'Lower' efficacy of UST
#IBDSky #GISky
academic.oup.com/ecco-jcc/adv...
- FIT is non-inferior to colonoscopy for CRC-related deaths at 10 years
n= 57404
Participation rates higher for FIT (39.9%) vs scope (31.8%)
CRC-deaths similar: FIT (0.24%) vs scope (0.22%)
#GISky #SurgSky
@thelancet.bsky.social
www.thelancet.com/journals/lan...
- FIT is non-inferior to colonoscopy for CRC-related deaths at 10 years
n= 57404
Participation rates higher for FIT (39.9%) vs scope (31.8%)
CRC-deaths similar: FIT (0.24%) vs scope (0.22%)
#GISky #SurgSky
@thelancet.bsky.social
www.thelancet.com/journals/lan...
Read more: gastro.org/news/new-gui...
🌟 #AI
Read more: gastro.org/news/new-gui...
🌟 #AI
#STASH trial @jasmohanbajaj.bsky.social @juanpabloarab.bsky.social @ebtapper.bsky.social @tonybreu.bsky.social
@blaneymd.medsky.social
journals.lww.com/ajg/abstract... #liversky
#STASH trial @jasmohanbajaj.bsky.social @juanpabloarab.bsky.social @ebtapper.bsky.social @tonybreu.bsky.social
@blaneymd.medsky.social
journals.lww.com/ajg/abstract... #liversky